| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.23 | 9e-11 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.21 | 1e-09 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.22 | 2e-09 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.22 | 2e-09 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.21 | 3e-09 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.2 | 4e-09 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.2 | 9e-09 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.21 | 1e-08 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.21 | 1e-08 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.21 | 2e-08 |